Malin Corporation has asked the High Court to approve a €110 million capital reduction to create distributable reserves for a well-flagged shareholder payout. Domiciled and headquartered in Dublin, the life sciences company is capitalising on the divestment of its stake in CG Oncology to return circa €45 million to its members. The background to the application was set out in an affidavit sworn by Fiona Dunlevy, executive director and company secretary of the PLC, grounding a successful application on Monday for the case to be fast-tracked into the commercial division of the High Court. On July 23, 2024, Malin announced…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .